Psilocybin rTMS for Treatment Resistant Depression
Status:
Not yet recruiting
Trial end date:
2027-05-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and feasibility of sequencing psilocybin
therapy with a short-duration, aiTBS protocol (Stanford Accelerated Intelligent
Neuromodulation Therapy, or SAINT) in individuals with treatment-resistant major depressive
disorder.